Calliditas Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-10-11 | Calliditas Therapeutics AB | Katayoun Welin-Berger | Other senior executive | Acquisition | 500 | 89 | SEK | 44 500 | 2021-10-07 |
| 2021-08-26 | Calliditas Therapeutics AB | Elmar Schnee | Chairman of the Board of Directors | Acquisition | 10 000 | 96,34 | SEK | 963 402,7 | 2021-08-24 |
| 2021-05-26 | Calliditas Therapeutics AB | Katayoun Welin-Berger | Other member of the company's administrative, management or supervisory body | Acquisition | 100 | 125,4 | SEK | 12 540 | 2021-05-24 |
| 2021-05-26 | Calliditas Therapeutics AB | Katayoun Welin-Berger | Other member of the company's administrative, management or supervisory body | Acquisition | 4 000 | 124,7 | SEK | 498 800 | 2021-05-24 |
| 2021-03-03 | Calliditas Therapeutics AB | Katayoun Welin-Berger | Other member of the company's administrative, management or supervisory body | Acquisition | 1 000 | 121 | SEK | 121 000 | 2021-02-24 |
| 2021-02-19 | Calliditas Therapeutics AB | Carl Fredrik Johansson | Chief Financial Officer (CFO) | Acquisition | 3 000 | 128,2 | SEK | 384 600 | 2021-02-17 |
| 2020-09-18 | Calliditas Therapeutics AB | Carl Fredrik Johansson | Ekonomi/finanschef | Disposal | 70 000 | 102,5 | SEK | 7 175 000 | 2020-09-15 |
| 2020-06-30 | Calliditas Therapeutics AB | Ann-Kristin Lena Myde | VP Project Management | Exercise increase | 73 750 | 42,36 | SEK | 3 124 050 | 2020-06-28 |
| 2020-06-30 | Calliditas Therapeutics AB | Ann-Kristin Lena Myde | VP Project Management | Exercise decrease | 73 750 | 0 | SEK | 0 | 2020-06-28 |
| 2020-06-25 | Calliditas Therapeutics AB | Carl Fredrik Johansson | Ekonomi/finanschef | Exercise increase | 81 250 | 42,36 | SEK | 3 441 750 | 2020-06-24 |
| 2020-06-25 | Calliditas Therapeutics AB | Carl Fredrik Johansson | Ekonomi/finanschef | Exercise decrease | 81 250 | 0 | SEK | 0 | 2020-06-24 |
| 2020-06-25 | Calliditas Therapeutics AB | Johan Häggblad | Chief Scientific Officer | Exercise decrease | 184 750 | 0 | SEK | 0 | 2020-06-24 |
| 2020-06-25 | Calliditas Therapeutics AB | Johan Häggblad | Chief Scientific Officer | Exercise increase | 184 750 | 42,36 | SEK | 7 826 010 | 2020-06-24 |
| 2020-06-25 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | VD | Exercise decrease | 369 500 | 0 | SEK | 0 | 2020-06-21 |
| 2020-06-25 | Calliditas Therapeutics AB | RENÉE AGUIAR LUCANDER | VD | Exercise increase | 369 500 | 42,36 | SEK | 15 652 020 | 2020-06-21 |
| 2020-06-18 | Calliditas Therapeutics AB | Hilde Furberg | Styrelseledamot/suppleant | Exercise increase | 29 500 | 42,36 | SEK | 1 249 620 | 2020-06-16 |
| 2020-06-18 | Calliditas Therapeutics AB | Hilde Furberg | Styrelseledamot/suppleant | Exercise decrease | 29 500 | 0 | SEK | 0 | 2020-06-16 |
| 2020-02-17 | Calliditas Therapeutics AB | Lennart Hansson | Styrelseledamot/suppleant | Acquisition | 3 000 | 112 | SEK | 336 000 | 2020-02-16 |
| 2019-12-04 | Calliditas Therapeutics AB | Thomas Eklund | Styrelseledamot/suppleant | Disposal | 5 250 | 69,45 | SEK | 364 612,5 | 2019-12-03 |
| 2019-12-04 | Calliditas Therapeutics AB | Thomas Eklund | Styrelseledamot/suppleant | Disposal | 16 000 | 67,71 | SEK | 1 083 360 | 2019-12-02 |